In a study from Mikol and colleagues in 26 MS patients, a total of 128 peptides showed some IgE reactivity (mean 4.9 per subject), compared to 59 among the 15 controls (mean 3.9 per subject) (26). The gene discussed is IGHE; the disease is myeloid sarcoma.